1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LIQUIDIA CORP
Liquidia Corp XNAS: LQDA

Liquidia Corp Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hyperte...

Read More
28.40 0.36 (1.28%)
192.48% Gain from 52W Low
1.4M
XNAS Volume

XNAS 17 Nov, 2025 4:11 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Liquidia Corp is on 18 Nov 2025 for the purpose of Jefferies London Healthcare Conference See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
4.3 / 100
Momentum Score
Technically Bullish
71.3 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
44
1Yr Price target upside is 55%
9 analysts

21

S

14

W

5

O

1

T

SWOT Analysis

Liquidia Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..